Concepedia
Publication | Open Access
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease
65
Citations
14
References
2025
Year
ClinicalTrials.gov Identifiers: NCT03367403 and NCT04437511.
Page 1